Partner
Peter De Ryck
Corporate and M&A
Private Equity & Venture Capital
Insolvency and Restructuring
peter.deryck@lydian.be
Lydian advised the family Van Gucht in the sale of Purna Pharmaceuticals to Ampersand Capital Partners
We are proud to have assisted the family Van Gucht, as founders and majority shareholders, in the sale of Purna Pharmaceuticals, to Ampersand Capital Partners.
Purna Pharmaceuticals has built a strong reputation as a reliable partner in the development and manufacturing of liquid and semi-solid pharmaceutical products, combining technical know-how with a strong client-focused approach.
Through this transaction, Purna joins forces with Ampersand and its portfolio company MedPharm, paving the way for the creation of an integrated transatlantic platform.
Lydian advised the sellers throughout the transaction. The team was composed of Peter De Ryck (Partner), Delphine Penninck (Counsel) and Viktor d'hooge (Associate).
Congratulations to all parties involved!
More information on the deal:
🔗 Ampersand Capital Partners: Ampersand Capital Partners Acquires Purna Pharmaceuticals | Ampersand
For any questions about this transaction or our legal services, feel free to reach out to our team.
Authors
-
Download VCARD
-
-
